Results 61 to 70 of about 96,262 (339)

How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study

open access: yesHarm Reduction Journal, 2023
Background Naloxone is a medication that can quickly reverse an opioid overdose. Syringe service programs (SSPs) are community-based prevention programs that provide a range of evidence-based interventions in the USA, including naloxone distribution ...
Barrot H. Lambdin   +7 more
doaj   +1 more source

SAFE – Home Opioid Management Education (SAFE-HOME) in older adults: a naloxone awareness program for home health workers

open access: yesDrugs in Context, 2021
Background: Older adults (≥65 years) have seen significant increases in opioid overdose deaths. Diversion of older adults’ opioid medication is also a contributor to opioid misuse.
Brianna M McQuade   +4 more
doaj   +1 more source

Messaging to Increase Public Support for Naloxone Distribution Policies in the United States: Results from a Randomized Survey Experiment. [PDF]

open access: yesPLoS ONE, 2015
Barriers to public support for naloxone distribution include lack of knowledge, concerns about potential unintended consequences, and lack of sympathy for people at risk of overdose.A randomized survey experiment was conducted with a nationally ...
Marcus A Bachhuber   +4 more
doaj   +1 more source

Towards Better Opioid Antagonists Using Deep Reinforcement Learning [PDF]

open access: yesarXiv, 2020
Naloxone, an opioid antagonist, has been widely used to save lives from opioid overdose, a leading cause for death in the opioid epidemic. However, naloxone has short brain retention ability, which limits its therapeutic efficacy. Developing better opioid antagonists is critical in combating the opioid epidemic.Instead of exhaustively searching in a ...
arxiv  

An opioid-like system regulating feeding behavior in C. elegans [PDF]

open access: yes, 2015
Neuropeptides are essential for the regulation of appetite. Here we show that neuropeptides could regulate feeding in mutants that lack neurotransmission from the motor neurons that stimulate feeding muscles. We identified nlp-24 by an RNAi screen of 115
Artyukhin, Alexander B.   +3 more
core   +2 more sources

Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine

open access: yesDrugs, 2019
Naloxone is a well-established essential medicine for the treatment of life-threatening heroin/opioid overdose in emergency medicine. Over two decades, the concept of ‘take-home naloxone’ has evolved, comprising pre-provision of an emergency supply to ...
J. Strang   +6 more
semanticscholar   +1 more source

Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program

open access: yesJAMA Network Open, 2020
Key Points Question Is there a benefit associated with take-home naloxone for overdose reversals supplied to patients who are receiving treatment for opioid use disorder?
Joanna G. Katzman   +7 more
semanticscholar   +1 more source

Naloxone Administration Route in Opioid Overdose: A Review of Vermont EMS Data [PDF]

open access: yes, 2017
Objective: Emergency Medical System (EMS) personnel administer the direct opioid antagonist naloxone in cases of opioid overdose via intramuscular (IM), intravenous (IV), subcutaneous (SQ), intraosseous (IO), or intranasal (IN) routes. Some early studies
LaMonda, Chris, MPH   +4 more
core   +1 more source

Naloxone dosing in the era of ultra-potent opioid overdoses: a systematic review.

open access: yesCJEM, 2020
OBJECTIVES Evaluate the relationship between naloxone dose (initial and cumulative) and opioid toxicity reversal and adverse events in undifferentiated and presumed fentanyl/ultra-potent opioid overdoses.
J. Moe   +10 more
semanticscholar   +1 more source

Effects of pharmacist-driven protocol on naloxone prescribing rates in two primary care clinics

open access: yesPreventive Medicine Reports, 2023
The Centers for Disease Control and Prevention (CDC) Guidelines for Prescribing Opioids for Chronic Pain recommend co-prescribing naloxone as a harm reduction strategy when there is an increased risk of opioid overdose.
Ashley Daffron   +3 more
doaj  

Home - About - Disclaimer - Privacy